Therapeutic applications of human umbilical cord-derived mesenchymal stem cell secretome in chronic inflammatory diseases and cancer: A recent update
Molecular Immunology · 2026
DOI: 10.1016/j.molimm.2026.01.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Immunology, 2026. Verfasst von Keerthi Nethaji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biotechnology lab, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Ins…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Secretome, Umbilical Cord, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council for Scientific and Industrial Research, South Africa, Chettinad Academy of Research and Education, CSIR.
Abstract (Originalsprache)
Chronic inflammatory disorders and cancer remain major global health challenges driven by persistent immune activation and tissue damage. The human umbilical cord-derived mesenchymal stem cell (hUC-MSC) secretome has emerged as a promising cell-free therapeutic alternative owing to its potent anti-inflammatory, immunomodulatory, and regenerative properties. Comprising of cytokines, chemokines, growth factors, and extracellular vesicles enriched with bioactive miRNAs, the hUC-MSC secretome exerts its effects primarily through paracrine signaling. For this review, relevant literature was collected from established databases, including ScienceDirect, PubMed, and Google Scholar, using key terms such as "hUC-MSC secretome," "chronic inflammation," "exosomes," "tumor microenvironment," and "preconditioning." The search focused on studies published within the last five years, emphasizing in vitro and in vivo preclinical studies, original research, and review articles. Only studies specifically exploring hUC-MSC-derived secretomes were included, whereas those addressing cell-based therapies or secretomes from other MSC sources were excluded. Cumulative findings indicate that the hUC-MSC secretome alleviates chronic inflammation by releasing anti-inflammatory cytokines such as IL-10 and TGF-β, as well as regulatory miRNAs such as miR-29a-3p, miR-100-5p, and miR-125b-5p, which act via key signaling pathways including PI3K/AKT, Wnt/β-catenin, and JAK/STAT. These mechanisms collectively mediate anti-inflammatory responses, suppress epithelial-mesenchymal transition, enhance chemosensitivity, and promote tissue repair. This review aims to consolidate the emerging evidence that positions the hUC-MSC secretome as a next-generation cell-free therapeutic strategy for chronic inflammatory diseases, including major cancers, inflammatory bowel disease, rheumatoid arthritis, and neurodegenerative disorders, while highlighting current limitations and strategies to enhance the therapeutic efficacy and clinical applicability of the hUC-MSC secretome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Biotechnology lab, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Chennai, Tamil Nadu, India.
- Medical Biotechnology lab, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Chennai, Tamil Nadu, India. Electronic address: antarab…
- Section of Human Anatomy, Department of Neuroscience, University of Padova, Italy.
- Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway. Electronic address: a.k.duttaroy@medisin.uio.no.
Förderung
- Council for Scientific and Industrial Research, South Africa
- Chettinad Academy of Research and Education
- CSIR
Zitieren
APA
Nethaji, K., Ashiq Shibili, P., Dey, A., Nambidi, S., Banerjee, A., Barbon, S., Pathak, S., & Duttaroy, A. K. (2026). Therapeutic applications of human umbilical cord-derived mesenchymal stem cell secretome in chronic inflammatory diseases and cancer: A recent update. Molecular Immunology. https://doi.org/10.1016/j.molimm.2026.01.006
Vancouver
Nethaji K, Ashiq Shibili P, Dey A, Nambidi S, Banerjee A, Barbon S, et al. Therapeutic applications of human umbilical cord-derived mesenchymal stem cell secretome in chronic inflammatory diseases and cancer: A recent update. Molecular Immunology. 2026. doi:10.1016/j.molimm.2026.01.006
BibTeX
@article{Nethaji2026,
author = {Nethaji, Keerthi and Ashiq Shibili, P and Dey, Amit and Nambidi, Sibin and Banerjee, Antara and Barbon, Silvia and Pathak, Surajit and Duttaroy, Asim K},
title = {Therapeutic applications of human umbilical cord-derived mesenchymal stem cell secretome in chronic inflammatory diseases and cancer: A recent update},
journal = {Molecular Immunology},
year = {2026},
doi = {10.1016/j.molimm.2026.01.006}
}
EUVIMED